Anthem, Inc. (ANTM)
(Delayed Data from NYSE)
$261.70 USD
+0.11 (0.04%)
Updated May 3, 2019 04:00 PM ET
After-Market: $261.69 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$261.70 USD
+0.11 (0.04%)
Updated May 3, 2019 04:00 PM ET
After-Market: $261.69 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Aetna (AET) Q1 Earnings Beat Estimates, Enrollment Declines
by Zacks Equity Research
Bottom-line growth and higher adjusted revenues in Health Care segment aid Aetna's (AET) first-quarter results. However, lower enrollment plays a spoilsport.
HCA Healthcare (HCA) Beats on Q1 Earnings, Keeps Guidance
by Zacks Equity Research
HCA Healthcare's (HCA) Q1 impresses with improved revenues, admission and a favorable impact of share buybacks.
Tenet Healthcare (THC) Q1 Earnings & Revenues Beat Estimates
by Zacks Equity Research
Tenet Healthcare's (THC) Q1 rides high on solid segmental performances.
Molina Healthcare (MOH) Tops Q1 Earnings, Updates '18 View
by Zacks Equity Research
Bottom-line growth plus lower expenses as well as medical care cost drive Molina Healthcare's (MOH) first-quarter results.
Company News for Apr 26, 2018
by Zacks Equity Research
Companies In The News are: ANTM,VIAB,F,AMGN
Anthem, Inc. (ANTM) Jumps: Stock Rises 6.2%
by Zacks Equity Research
Anthem (ANTM) was a big mover last session, as the company saw its shares rise more than 6% on the day amid huge volumes.
Anthem's (ANTM) Q1 Earnings Beat Estimates
by Zacks Equity Research
Anthem (ANTM) came out with operating earnings of $5.41 per share, which beat the Zacks Consensus Estimate of $4.83.
Anthem (ANTM) Beats on Q1 Earnings, Raises '18 Guidance
by Zacks Equity Research
Strong performance across segments supports Anthem's (ANTM) first-quarter results.
Healthcare Stock Q1 Earnings Due on Apr 25: ANTM, UHS, PRAH
by Zacks Equity Research
Severe flu activity in the first quarter should benefit companies in the health care space, while insurers might feel the pinch from the same.
Anthem (ANTM) Q1 Earnings: What's in Store for the Stock?
by Zacks Equity Research
Anthem's (ANTM) first-quarter earnings might gain from a solid Government business. However, persistent softness in Individual business is likely to affect overall results.
UnitedHealth (UNH) Q1 Earnings to Gain From Optum Revenues
by Zacks Equity Research
UnitedHealth (UNH) Q1 earnings should see an upside from higher revenues in its health services segment named Optum.
Medicare Rate Up More than Expected, Health Insurers to Gain
by Zacks Equity Research
Increase in Medicare Advantage reimburse rates bodes well for health insurers.
Retailers May Shake Healthcare: 4 Stocks for a Fit Portfolio
by Zacks Equity Research
Retailers foray into the healthcare space might shake the industry. Yet some established players still looks attractive.
5 Reasons Why Centene is an Attractive Bet for Investors
by Zacks Equity Research
Centene (CNC) can be considered a lucrative investment option on the back of top-line growth, inorganic strategies and a solid financial health.
Is Anthem (ANTM) a Great Stock for Value Investors Right Now?
by Zacks Equity Research
Is Anthem (ANTM) a great pick from the value investor's perspective right now? Read on to know more.
Buy These 3 Stocks as Healthcare Continues to Shift Gears
by Zacks Equity Research
Mergers and acquisition in the healthcare industry should aid long term-growth for companies.
5 Reasons Why Anthem (ANTM) is a Lucrative Investment Option
by Zacks Equity Research
Anthem (ANTM) appears an impressive investment option on the back of rising membership, favorable investment income as well as solid financial health.
The Zacks Analyst Blog Highlights: Ulta, Ross, Anthem, General Dynamics and Nasdaq
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Ulta, Ross, Anthem, General Dynamics and Nasdaq
Cigna, Express Script Deal to Continue Healthcare Reshuffle
by Zacks Equity Research
Cigna's (CI) acquisition of Express Scripts should transform it into a more diversified entity.
Women-Led Firms Outperform in 9-Year Bull Run: 5 Top Picks
by Sweta Killa
We have highlighted five stocks that are headed by women and have easily crushed the nine-year bull market.
Universal Health (UHS) Q4 Earnings, Revenues Beat Estimates
by Zacks Equity Research
Solid segmental performance drives Universal Health's (UHS) fourth-quarter results.
Community Health's (CYH) Q4 Loss Narrower Than Expected
by Zacks Equity Research
Lower admission hurts Community Health's (CYH) fourth-quarter results.
Teladoc (TDOC) Q4 Loss Wider Than Expected, Revenues Beat
by Zacks Equity Research
Teladoc (TDOC) earnings were aided by membership growth and increased visits.
Tenet Healthcare (THC) Q4 Earnings & Revenues Top Estimates
by Zacks Equity Research
Strong segmental performances along with solid expense management aid Tenet Healthcare's (THC) Q4.
LifePoint Health (LPNT) Q4 Earnings Miss on Lower Revenues
by Zacks Equity Research
LifePoint Health (LPNT) fails to beat the earnings and revenue estimates in the fourth quarter. Equivalent admissions decline 3% year over year.